Recent Operational Highlights

Related by string. * recents . recenter . recent : RECENT FIRST ROUND HISTORY . Recent Recommended Trades . Recent Past Current / opera tional . OPERATIONAL . operational : Initial Operational Capability . operational efficiency . Operational Highlights / highlights . highlighted . highlighting : Zacks Analyst Blog Highlights . Balance Sheet Highlights . Highlights Unaudited * *

Related by context. Frequent words. (Click for all words.) 58 Operational Highlights 55 Positive Cash Flow 53 -Soft soled shoes 52 -Edgewater Networks 52 Record Second Quarter 52 Milestone Payment 50 Notice Regarding 50 Quarter Results 50 Recurring Revenue 50 IN MILLIONS 50 Key Milestones 50 Capacity Expansion 50 Guides FY# 50 -0 - 50 Product Offerings 50 Secures Financing 49 Record Third Quarter 49 Q2 FY# [001] 49 Achieves Record 49 Significant Increase 49 Workforce Reduction 49 Single Dose 49 Summarizes 49 Significantly Improved 48 Revenues Increase 48 Updates Guidance 48 Lithium Batteries 48 Releases Second Quarter 48 Thin Film Solar 48 Provides Guidance 47 FY# FY# [002] 47 More Than Doubled 47 follows > 47 Cost Reductions 47 Previously Announced 47 -Borgata Winter 46 Store Openings 46 Provides Updates 46 Clinical Trial Results 46 Share Repurchases 46 Q3 FY# [001] 46 Supplementary Data 46 Significantly Reduce 46 FDA Clearance 46 Study Evaluating 46 Contracts Totaling 46 Guidance Quick Facts 46 Fifth Consecutive 45 Pivotal Study 45 Resume Trading BULLETIN DATE 45 Mechel Announces 45 -Genereaux 45 Significantly Increases 45 Ninth Consecutive 45 QUARTERLY REPORT 45 Achieves Milestone 45 Clinical Trials Update 45 Momentum Continues 45 Subsidiary Receives 45 Patient Enrollment 45 Significantly Reduces 45 Performance Metrics 45 Profitable Quarter 44 Hydrogen Fuel 44 Metastatic Melanoma 44 FDA Clears 44 Significantly Improves 44 Japanese Stocks Climb 44 Closes Financing 44 Highly Efficient 44 STRATEGY ANALYTICS 44 Confirmatory 44 FY# Guidance 44 -Unprovoked 43 4Q Loss Widens 43 Study Demonstrates 43 Broadened 43 Commenced 43 Phase III Clinical Trial 43 Quantifies 43 Organizational Changes 43 Completes Financing 43 Preliminary Results 43 Growth Accelerates 43 Announce Completion 43 Explosive Growth 43 Gains Traction 43 Deferrals 43 Deliverables 43 Q4 FY# [001] 43 Phase III Trial 43 Hepatocellular Carcinoma 43 Segmental 43 Smallpox Vaccine 43 Growth Spurt 42 Yearend 42 =shen 42 SBIR Grant 42 Appendix 4E 42 Filing Deadline 42 Accelerate Growth

Back to home page